查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828123

2025年血紅素檢測全球市場報告

Hemoglobin Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，血紅素檢測市場規模強勁成長，從2024年的26.4億美元增加至2025年的27.9億美元，複合年成長率為5.6%。預測期內的成長歸因於貧血盛行率的上升、孕產婦保健計畫、捐血計畫、慢性病管理以及全球健康意識提升宣傳活動。

預計未來幾年血紅素檢測市場規模將強勁成長，到2029年將達到39.1億美元，複合年成長率為8.8%。預測期內的成長歸因於醫療保健投資的增加、與慢性病管理的整合、就地檢驗的擴展、對預防保健的重視程度的提高以及全球衛生大流行病的防範。預測期內的主要趨勢包括遠端醫療和遠端監控、技術進步、家用檢測套組、與電子健康記錄(EHR) 的整合以及對無創技術的關注。

血紅蛋白檢測是一種測量血液中血紅素濃度的醫療程序。血紅蛋白是紅血球中的一種蛋白質，在將氧氣從肺部輸送到身體組織和器官的過程中發揮著至關重要的作用。

血紅蛋白檢測的主要產品類型包括試劑和耗材以及儀器。血紅素檢測市場的試劑和耗材部分包括血紅素檢測過程中使用的各種化學試劑和耗材。血紅素檢測採用各種技術，例如層析法、免疫測量和光強度。這些檢測產品應用於各種環境，包括醫院、診所、實驗室、居家醫療和血庫。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供血紅蛋白檢測市場統計數據，例如全球血紅蛋白檢測行業規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的血紅蛋白檢測細分市場、市場趨勢和機遇，以及您在血紅蛋白檢測行業取得成功所需的數據。本血紅蛋白檢測市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.8%的預測成長率，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這種影響，因為來自墨西哥和丹麥等主要地區的非侵入式脈搏血氧飽和度感測器和微流體檢測試劑盒的供應鏈中斷，這可能導致血氧讀數降低和緊急醫療費用增加。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也可能波及更廣泛的地區。

隨著糖尿病等慢性疾病的日益流行，血紅素檢測市場可望持續成長。糖尿病是一種以胰島素生成和利用不足為特徵的慢性疾病，需要定期進行糖化血紅蛋白 (HbA1c) 檢測。這些檢測由美國糖尿病協會 ( 美國 Diabetes Association) 推薦，在糖尿病診斷中發揮關鍵作用。目前，超過 3,400 萬美國人患有糖尿病，另有 8,800 萬人面臨患病風險，因此對 HbA1c 檢測設備的需求只會持續成長。此外，全球預測顯示，糖尿病患者數量將大幅增加，到 2045 年將達到 783,700 人，凸顯了糖化血紅蛋白檢測設備在慢性疾病管理中的關鍵作用。

貧血盛行率的上升預計將在未來幾年推動血紅蛋白檢測市場的成長。貧血是一種表現為紅血球缺乏或血紅素含量減少的疾病。血紅蛋白是紅血球中負責將氧氣輸送到身體組織的蛋白質。貧血盛行率的上升推動了對血紅蛋白檢測的需求，這是由於人們對早期發現和定期檢測的需求日益成長，人們的認知度不斷提高，對預防性醫療保健的重視以及貧血相關疾病的增多。這些因素共同推動了市場的顯著成長，因為診斷服務對於大規模識別和管理貧血至關重要。例如，華盛頓大學醫學院獨立研究中心健康指標與評估研究所於2023年7月發布的報告估計，全球約四分之一的人口患有貧血，其中女性、孕婦、女孩和五歲以下兒童的貧血盛行率顯著增加。因此，貧血盛行率的上升正在推動血紅蛋白檢測市場的成長。

預計不斷成長的醫療保健支出將推動血紅蛋白檢測市場的未來成長。醫療保健支出是指特定地區、國家或經濟體在特定期間內撥給醫療保健部門的公共和私人資金總額。不斷成長的醫療保健支出將透過支援先進的診斷技術、擴大檢測管道以及推廣用於貧血檢測和管理的綜合篩檢舉措來促進血紅蛋白檢測的發展。例如，英國國家統計局報告稱，2022年至2023年，醫療保健總支出名義上將增加5.6%，而2022年的增幅僅為0.9%。因此，不斷成長的醫療保健支出是血紅蛋白檢測市場的主要驅動力。

血紅蛋白檢測市場的主要企業正在開發創新的指尖採血檢測解決方案，使患者能夠在家中方便地監測血紅蛋白水平，支持貧血的早期發現，並加強整體健康管理。這些先進的指尖採血檢測方法只需簡單的指尖採血即可快速輕鬆地採集血樣，使診斷檢測更有效率、更侵入性更小。例如，2024 年 2 月，美國健康科技公司 Sanguina Inc. 推出了 AnemoCheck Home，這是第一個獲得 FDA 批准的家用血紅蛋白檢測套組。 AnemoCheck Home 旨在透過簡單的指尖採血提供準確的血紅蛋白測量。這款使用者友善的試劑套件包含所有必要的組件，包括測試設備和清晰的說明，無需前往實驗室即可進行測試。 AnemoCheck Home 不僅使患者能夠定期監測血紅素水平，還可以促進貧血等潛在健康問題的早期發現。

血紅蛋白檢測市場的主要企業正在推出創新解決方案，例如本土快速血紅蛋白檢測試劑盒，以便快速準確地評估血紅蛋白水平，提高偏遠地區患者的可及性，並及時診斷和管理貧血等疾病。這些本土快速血紅素檢測套組檢測套組檢測套組SenzHb。 SenzHb 是一種尖端診斷工具，可透過簡單、使用者友好的介面快速且準確地測量血紅素水平。這種創新試劑套件只需抽取少量血液，適用於各種環境，包括農村和服務不足地區。

血紅素檢測市場的主要企業包括雅培實驗室公司、拜耳醫療保健公司、丹納赫公司、賽默飛世爾科技公司、羅氏公司、Bio-Rad Laboratories Inc.、第一三共株式會社、ACON Laboratories Inc.、DiaSys Diagnostic Systems GmbH、EKF Diagnostics Holdings PLC、E.Enoscnosr. Inc.、貝克曼庫爾特診斷有限公司、Diazyme Laboratories Inc.、Radiometer A/S、Sysmex Corporation、BioMedomics Inc.、Hemosure Inc.、Humasis Co. Ltd.、Immunostics Inc.、LifeSign LLC、Medix Biochemica Oy AB、NanoenTek Inc. Corp.、西門子醫療有限公司、邁瑞醫療國際有限公司、日本光電株式會社和東曹株式會社。

2024年，亞太地區和北美是血紅素檢測市場最大的地區。預計亞太地區將成為預測期內全球血紅素檢測市場成長最快的地區。血紅素檢測市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

血紅素檢測市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

血紅蛋白檢測市場涵蓋提供氰化血紅蛋白、Vanzetti 疊氮化物高鐵血紅蛋白、無試劑非侵入性方法以及血紅蛋白電泳等服務的營業單位所獲得的收益。市場規模包括服務提供者銷售或包含在服務產品中的相關商品的價值。它僅包括企業之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血紅素檢測：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球血紅素檢測市場：成長率分析
  • 全球血紅素檢測市場表現：規模與成長，2019-2024
  • 全球血紅素檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球血紅素檢測：總潛在市場（TAM）

第6章 市場細分

  • 全球血紅素檢測市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 試劑和耗材
  • 裝置
  • 全球血紅素檢測市場（依技術、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 層析法
  • 免疫檢測
  • 光強度
  • 其他
  • 全球血紅素檢測市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 實驗室
  • 居家照護
  • 血庫
  • 其他
  • 全球血紅素檢測市場：試劑和耗材細分、按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 血紅素檢測套組
  • 控制解決方案
  • 測試條
  • 品管產品
  • 全球血紅素檢測市場：儀器細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血紅素儀
  • 分析器
  • 照護現場設備
  • 實驗設備

第7章 區域和國家分析

  • 全球血紅素檢測市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球血紅素檢測市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 血紅素檢測市場：競爭格局
  • 血紅素檢測市場：公司簡介
    • Abbott Laboratories Inc.
    • Bayer Medical Care Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche AG

第31章：其他領先和創新企業

  • Bio-Rad Laboratories Inc.
  • Daiichi Sankyo Inc.
  • ACON Laboratories Inc.
  • DiaSys Diagnostic Systems GmbH
  • EKF Diagnostics Holdings PLC
  • Epinex Diagnostics Inc.
  • Erba Diagnostics Inc.
  • ARKRAY Inc.
  • Beckman Coulter Diagnostics Ltd.
  • Diazyme Laboratories Inc.
  • Radiometer A/S
  • Sysmex Corporation
  • BioMedomics Inc.
  • Hemosure Inc.
  • Humasis Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年血紅素檢測市場：提供新機會的國家
  • 2029 年血紅素檢測市場：細分市場帶來新機會
  • 2029年血紅素檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24193u

Hemoglobin testing is a medical procedure designed to measure the concentration of hemoglobin in the blood. Hemoglobin, a protein found in red blood cells, plays a crucial role in transporting oxygen from the lungs to the tissues and organs of the body.

The primary types of products in hemoglobin testing include reagents and consumables, as well as equipment. The reagents and consumables segment in the hemoglobin testing market encompasses various chemical reagents and consumable products utilized in the process of hemoglobin testing. Various technologies are employed for hemoglobin testing, including chromatography, immunoassay, spectrophotometry, and others. These testing products find application in diverse settings such as hospitals, clinics, laboratories, home care settings, blood banks, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemoglobin testing market research report is one of a series of new reports from The Business Research Company that provides hemoglobin testing market statistics, including hemoglobin testing industry global market size, regional shares, competitors with a hemoglobin testing market share, detailed hemoglobin testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin testing industry. This hemoglobin testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin testing market size has grown strongly in recent years. It will grow from $2.64 billion in 2024 to $2.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the prevalence of anemia, maternal health initiatives, blood donation programs, chronic disease management, and global health awareness campaigns.

The hemoglobin testing market size is expected to see strong growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising healthcare investments, integration with chronic disease management, point-of-care testing expansion, increasing focus on preventive healthcare, and global health pandemic preparedness. Major trends in the forecast period include telemedicine and remote monitoring, technological advancements, home-based testing kits, integration with electronic health records (EHR), and a focus on non-invasive methods.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for non-invasive pulse CO-oximetry sensors and microfluidic testing cartridges, sourced from key regions such as Mexico and Denmark, which could lead to compromised blood oxygen measurements and increased emergency medicine expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The hemoglobin testing market is poised for growth, driven by the increasing prevalence of chronic disorders such as diabetes. Diabetes, a chronic condition characterized by insufficient insulin production or utilization, necessitates regular monitoring through Hemoglobin A1c tests (HbA1c). These tests, recommended by the American Diabetes Association, play a crucial role in diabetes diagnosis. With over 34 million Americans having diabetes and an additional 88 million at risk, the demand for HbA1c testing devices is set to rise. Furthermore, global projections indicate a substantial increase in diabetes cases, reaching 783,700 individuals by 2045, emphasizing the pivotal role of hemoglobin A1c testing devices in managing chronic disorders.

The increasing incidence of anemia is expected to enhance the growth of the hemoglobin testing market in the future. Anemia is a medical condition marked by a shortage of red blood cells or a reduction in the amount of hemoglobin, a protein in red blood cells responsible for transporting oxygen to body tissues. The rising prevalence of anemia fuels the demand for hemoglobin testing, driven by a heightened need for early detection, routine testing, greater awareness, a focus on preventive healthcare, and an increase in anemia-related conditions. These factors collectively contribute to the market's significant growth, as diagnostic services are crucial in identifying and managing anemia on a larger scale. For example, a report published in July 2023 by the Institute for Health Metrics and Evaluation, an independent research center at the University of Washington School of Medicine, estimated that about one-fourth of the global population is anemic, with a notable increase in cases among women, pregnant women, young girls, and children under five. Therefore, the rising prevalence of anemia is driving the growth of the hemoglobin testing market.

The increasing healthcare expenditure is projected to drive the growth of the hemoglobin testing market in the future. Healthcare expenditure refers to the total funds, both public and private, allocated to the healthcare sector within a specific geographical area, country, or economy over a defined period. A rise in healthcare spending enhances hemoglobin testing by supporting advanced diagnostic technologies, increasing access to testing, and promoting comprehensive screening initiatives for the detection and management of anemia. For example, a report from the Office for National Statistics, a UK-based government department, revealed that total healthcare expenditure grew by 5.6% in nominal terms from 2022 to 2023, compared to a mere 0.9% increase in 2022. Thus, the growing healthcare expenditure is a key driver of the hemoglobin testing market.

Leading companies in the hemoglobin testing market are creating innovative fingerstick blood test solutions to enable patients to conveniently monitor their hemoglobin levels at home, support early detection of anemia, and enhance overall health management. These advanced fingerstick blood test methods allow for quick and easy blood sample collection through a simple finger prick, making diagnostic testing more efficient and less invasive. For example, in February 2024, Sanguina Inc., a health technology company based in the U.S., launched AnemoCheck Home, the first FDA-cleared home hemoglobin test kit. AnemoCheck Home is designed to provide users with accurate hemoglobin readings using a simple finger prick. This user-friendly kit includes all the necessary components, such as a testing device and clear instructions, enabling individuals to conduct the test without needing a laboratory visit. AnemoCheck Home not only allows patients to regularly monitor their hemoglobin levels but also promotes early detection of potential health issues like anemia.

Key companies in the hemoglobin testing market are introducing innovative solutions like indigenous rapid hemoglobin testing kits to deliver quick and accurate assessments of hemoglobin levels, improve accessibility for patients in remote areas, and enable timely diagnosis and management of conditions such as anemia. These indigenous rapid hemoglobin testing kits are locally developed diagnostic tools designed to efficiently measure hemoglobin levels in individuals. For instance, in June 2023, the Indian Institute of Toxicology Research (IITR), a research organization based in India, launched SenzHb, a rapid hemoglobin testing kit. SenzHb is a state-of-the-art diagnostic tool that enables fast and precise measurement of hemoglobin levels through a simple, user-friendly interface. This innovative kit requires only a small blood sample, making it suitable for use in various settings, including rural and underserved communities.

Major companies operating in the hemoglobin testing market include Abbott Laboratories Inc., Bayer Medical Care Inc., Danaher Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Daiichi Sankyo Inc., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC, Epinex Diagnostics Inc., Erba Diagnostics Inc., ARKRAY Inc., Beckman Coulter Diagnostics Ltd., Diazyme Laboratories Inc., Radiometer A/S, Sysmex Corporation, BioMedomics Inc., Hemosure Inc., Humasis Co. Ltd., Immunostics Inc., LifeSign LLC, Medix Biochemica Oy AB, NanoenTek Inc., Nova Biomedical Corp., Siemens Healthcare GmbH, Mindray Medical International Limited, Nihon Kohden Corporation, Tosoh Corporation

Asia-Pacific and North America were the largest region in the hemoglobin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hemoglobin testing market report during the forecast period. The regions covered in the hemoglobin testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemoglobin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemoglobin testing market consists of revenues earned by entities by providing services such as hemoglobin-cyanide, vanzetti's azide methemoglobin, reagent-less, non-invasive methods, and hemoglobin electrophoresis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Consumables; Equipment
  • 2) By Technology: Chromatography; Immunoassay; Spectrophotometry; Other Technologies
  • 3) By End User: Hospitals; Clinics; Laboratories; Home Care Settings; Blood Banks; Other End Users
  • Subsegments:
  • 1) By Reagents And Consumables: Hemoglobin Testing Kits; Control Solutions; Test Strips; Quality Control Products
  • 2) By Equipment: Hemoglobin Meters; Analyzers; Point-Of-Care Devices; Laboratory Equipment
  • Companies Mentioned: Abbott Laboratories Inc.; Bayer Medical Care Inc.; Danaher Corporation; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; Bio-Rad Laboratories Inc.; Daiichi Sankyo Inc.; ACON Laboratories Inc.; DiaSys Diagnostic Systems GmbH; EKF Diagnostics Holdings PLC; Epinex Diagnostics Inc.; Erba Diagnostics Inc.; ARKRAY Inc.; Beckman Coulter Diagnostics Ltd.; Diazyme Laboratories Inc.; Radiometer A/S; Sysmex Corporation; BioMedomics Inc.; Hemosure Inc.; Humasis Co. Ltd.; Immunostics Inc.; LifeSign LLC; Medix Biochemica Oy AB; NanoenTek Inc.; Nova Biomedical Corp.; Siemens Healthcare GmbH; Mindray Medical International Limited; Nihon Kohden Corporation; Tosoh Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemoglobin Testing Market Characteristics

3. Hemoglobin Testing Market Trends And Strategies

4. Hemoglobin Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemoglobin Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemoglobin Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemoglobin Testing Market Growth Rate Analysis
  • 5.4. Global Hemoglobin Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemoglobin Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemoglobin Testing Total Addressable Market (TAM)

6. Hemoglobin Testing Market Segmentation

  • 6.1. Global Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Consumables
  • Equipment
  • 6.2. Global Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chromatography
  • Immunoassay
  • Spectrophotometry
  • Other Technologies
  • 6.3. Global Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Laboratories
  • Home Care Settings
  • Blood Banks
  • Other End Users
  • 6.4. Global Hemoglobin Testing Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin Testing Kits
  • Control Solutions
  • Test Strips
  • Quality Control Products
  • 6.5. Global Hemoglobin Testing Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin Meters
  • Analyzers
  • Point-Of-Care Devices
  • Laboratory Equipment

7. Hemoglobin Testing Market Regional And Country Analysis

  • 7.1. Global Hemoglobin Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemoglobin Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemoglobin Testing Market

  • 8.1. Asia-Pacific Hemoglobin Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemoglobin Testing Market

  • 9.1. China Hemoglobin Testing Market Overview
  • 9.2. China Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemoglobin Testing Market

  • 10.1. India Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemoglobin Testing Market

  • 11.1. Japan Hemoglobin Testing Market Overview
  • 11.2. Japan Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemoglobin Testing Market

  • 12.1. Australia Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemoglobin Testing Market

  • 13.1. Indonesia Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemoglobin Testing Market

  • 14.1. South Korea Hemoglobin Testing Market Overview
  • 14.2. South Korea Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemoglobin Testing Market

  • 15.1. Western Europe Hemoglobin Testing Market Overview
  • 15.2. Western Europe Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemoglobin Testing Market

  • 16.1. UK Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemoglobin Testing Market

  • 17.1. Germany Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemoglobin Testing Market

  • 18.1. France Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemoglobin Testing Market

  • 19.1. Italy Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemoglobin Testing Market

  • 20.1. Spain Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemoglobin Testing Market

  • 21.1. Eastern Europe Hemoglobin Testing Market Overview
  • 21.2. Eastern Europe Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemoglobin Testing Market

  • 22.1. Russia Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemoglobin Testing Market

  • 23.1. North America Hemoglobin Testing Market Overview
  • 23.2. North America Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemoglobin Testing Market

  • 24.1. USA Hemoglobin Testing Market Overview
  • 24.2. USA Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemoglobin Testing Market

  • 25.1. Canada Hemoglobin Testing Market Overview
  • 25.2. Canada Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemoglobin Testing Market

  • 26.1. South America Hemoglobin Testing Market Overview
  • 26.2. South America Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemoglobin Testing Market

  • 27.1. Brazil Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemoglobin Testing Market

  • 28.1. Middle East Hemoglobin Testing Market Overview
  • 28.2. Middle East Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemoglobin Testing Market

  • 29.1. Africa Hemoglobin Testing Market Overview
  • 29.2. Africa Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemoglobin Testing Market Competitive Landscape And Company Profiles

  • 30.1. Hemoglobin Testing Market Competitive Landscape
  • 30.2. Hemoglobin Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer Medical Care Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. Hemoglobin Testing Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Daiichi Sankyo Inc.
  • 31.3. ACON Laboratories Inc.
  • 31.4. DiaSys Diagnostic Systems GmbH
  • 31.5. EKF Diagnostics Holdings PLC
  • 31.6. Epinex Diagnostics Inc.
  • 31.7. Erba Diagnostics Inc.
  • 31.8. ARKRAY Inc.
  • 31.9. Beckman Coulter Diagnostics Ltd.
  • 31.10. Diazyme Laboratories Inc.
  • 31.11. Radiometer A/S
  • 31.12. Sysmex Corporation
  • 31.13. BioMedomics Inc.
  • 31.14. Hemosure Inc.
  • 31.15. Humasis Co. Ltd.

32. Global Hemoglobin Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin Testing Market

34. Recent Developments In The Hemoglobin Testing Market

35. Hemoglobin Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Hemoglobin Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemoglobin Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemoglobin Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer